AustralianSuper’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.9M | Sell |
104,673
-12,613
| -11% | -$3.75M | 0.16% | 115 |
|
|
2025
Q4 | $32M | Sell |
117,286
-22,111
| -16% | -$6.01M | 0.15% | 118 |
|
|
2025
Q3 | $37.7M | Sell |
139,397
-198,835
| -59% | -$54.1M | 0.18% | 103 |
|
|
2025
Q2 | $93.2M | Sell |
338,232
-83,477
| -20% | -$22.7M | 0.47% | 54 |
|
|
2025
Q1 | $112M | Sell |
421,709
-455,971
| -52% | -$112M | 0.63% | 47 |
|
|
2024
Q4 | $204M | Sell |
877,680
-39,750
| -4% | -$9.14M | 0.96% | 22 |
|
|
2024
Q3 | $202M | Sell |
917,430
-305,172
| -25% | -$63.1M | 1.01% | 28 |
|
|
2024
Q2 | $240M | Sell |
1,222,602
-49,057
| -4% | -$10.1M | 1.39% | 16 |
|
|
2024
Q1 | $270M | Buy |
1,271,659
+281,249
| +28% | +$59.1M | 1.58% | 12 |
|
|
2023
Q4 | $209M | Sell |
990,410
-218,798
| -18% | -$46.7M | 1.25% | 20 |
|
|
2023
Q3 | $242M | Buy |
1,209,208
+908
| +0.1% | +$180K | 1.57% | 12 |
|
|
2023
Q2 | $224M | Sell |
1,208,300
-41,552
| -3% | -$7.68M | 1.42% | 15 |
|
|
2023
Q1 | $239M | Buy |
1,249,852
+207,607
| +20% | +$37.5M | 1.46% | 16 |
|
|
2022
Q4 | $176M | Sell |
1,042,245
-229,061
| -18% | -$39.8M | 1.17% | 25 |
|
|
2022
Q3 | $225K | Buy |
1,271,306
+10,559
| +0.8% | +$2.09M | 1.6% | 21 |
|
|
2022
Q2 | $258K | Buy |
1,260,747
+238,555
| +23% | +$50.6M | 1.59% | 16 |
|
|
2022
Q1 | $243K | Hold |
1,022,192
| – | – | 1.32% | 30 |
|
|
2021
Q4 | $232K | Buy |
1,022,192
+2,577
| +0.3% | +$567K | 1.21% | 34 |
|
|
2021
Q3 | $197M | Hold |
1,019,615
| – | – | 1.27% | 32 |
|
|
2021
Q2 | $217M | Hold |
1,019,615
| – | – | 1.51% | 29 |
|
|
2021
Q1 | $208M | Sell |
1,019,615
-352,598
| -26% | -$69.4M | 1.63% | 26 |
|
|
2020
Q4 | $250M | Buy |
1,372,213
+119,390
| +10% | +$20.3M | 1.87% | 17 |
|
|
2020
Q3 | $210M | Buy |
1,252,823
+188,503
| +18% | +$31.8M | 1.79% | 18 |
|
|
2020
Q2 | $173M | Buy |
1,064,320
+17,308
| +2% | +$3.1M | 1.68% | 15 |
|
|
2020
Q1 | $181M | Sell |
1,047,012
-123,778
| -11% | -$24.6M | 2.32% | 11 |
|
|
2019
Q4 | $235M | Sell |
1,170,790
-243,788
| -17% | -$50M | 1.98% | 18 |
|
|
2019
Q3 | $299M | Hold |
1,414,578
| – | – | 2.83% | 6 |
|
|
2019
Q2 | $275M | Buy |
1,414,578
+142,552
| +11% | +$26.3M | 2.64% | 10 |
|
|
2019
Q1 | $209M | Buy |
1,272,026
+149,399
| +13% | +$26.4M | 2.19% | 17 |
|
|
2018
Q4 | $211M | Buy |
1,122,627
+110,300
| +11% | +$20.4M | 3.28% | 9 |
|
|
2018
Q3 | $172M | Buy |
+1,012,327
| New | +$170M | 3.26% | 19 |
|
Other funds holding CME
VCM
VPM
AustralianSuper's CME Position: Q1 2026 in Review
AustralianSuper reduced its CME Group (CME) stake by 11% in Q1 2026, selling an estimated $3.75M and leaving 104,673 shares worth $30.9M. The position accounts for 0.16% of the portfolio, ranked #115.
AustralianSuper first reported a position in CME in Q3 2018 and has held it in 31 quarters since. The position peaked at $299M in Q3 2019. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- AustralianSuper held 104,673 shares of CME Group worth $30.9M as of Q1 2026.
- AustralianSuper sold 12,613 CME Group shares in Q1 2026, an estimated $3.75M.
- CME Group made up 0.16% of AustralianSuper's portfolio in Q1 2026, its #115 holding.
- AustralianSuper first reported a position in CME Group in Q3 2018 and has held it in 31 quarters since.
- AustralianSuper's CME Group position peaked at $299M in Q3 2019.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on AustralianSuper's 13F filing for Q1 2026, filed 7 May 2026.